Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19494719rdf:typepubmed:Citationlld:pubmed
pubmed-article:19494719lifeskim:mentionsumls-concept:C1533585lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0138741lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0599295lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0546816lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C1336641lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C1515985lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0180683lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C1551083lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C1548161lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:19494719lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:19494719pubmed:issue7lld:pubmed
pubmed-article:19494719pubmed:dateCreated2009-11-6lld:pubmed
pubmed-article:19494719pubmed:abstractTextThe recently identified TMPRSS2: ERG fusion gene is a candidate oncogene for prostate cancer (PCa).lld:pubmed
pubmed-article:19494719pubmed:languageenglld:pubmed
pubmed-article:19494719pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19494719pubmed:citationSubsetIMlld:pubmed
pubmed-article:19494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19494719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19494719pubmed:statusMEDLINElld:pubmed
pubmed-article:19494719pubmed:monthJullld:pubmed
pubmed-article:19494719pubmed:issn1720-8386lld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:LuzzattoLLlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:FortiGGlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:BaldiEElld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:OrlandoCClld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:BonaccorsoJJlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:LaneA EAElld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:JhanwarS CSClld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:CariniMMlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:FangYYlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:Seri?VVlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:KrauszCClld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:PaglieraniMMlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:NutiFFlld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:Proietti-Pann...lld:pubmed
pubmed-article:19494719pubmed:authorpubmed-author:MasieriLLlld:pubmed
pubmed-article:19494719pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19494719pubmed:volume32lld:pubmed
pubmed-article:19494719pubmed:ownerNLMlld:pubmed
pubmed-article:19494719pubmed:authorsCompleteYlld:pubmed
pubmed-article:19494719pubmed:pagination590-6lld:pubmed
pubmed-article:19494719pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:meshHeadingpubmed-meshheading:19494719...lld:pubmed
pubmed-article:19494719pubmed:year2009lld:pubmed
pubmed-article:19494719pubmed:articleTitlePersistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results.lld:pubmed
pubmed-article:19494719pubmed:affiliationUnit of Andrology, Department of Clinical Physiopathology, University of Florence, Florence, Italy. l.bonaccorsi@dfc.unifi.itlld:pubmed
pubmed-article:19494719pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19494719pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2078entrezgene:pubmedpubmed-article:19494719lld:entrezgene
entrez-gene:7113entrezgene:pubmedpubmed-article:19494719lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19494719lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19494719lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19494719lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19494719lld:pubmed